v3.26.1
Segment and Geographic Information - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]        
Total revenue, net $ 418,761 $ 415,605 $ 810,679 $ 798,258
Cost of goods sold 199,017 206,273 373,953 394,494
Research and development 24,253 26,997 47,754 51,725
Selling, general & administrative 172,436 179,890 350,671 361,387
Intangible asset amortization 3,770 3,754 7,546 7,458
Goodwill impairment charge 0 511,365 0 511,365
Total costs and expenses 399,476 928,279 779,924 1,326,429
Operating income (loss) 19,285 (512,674) 30,755 (528,171)
Interest income 4,267 4,710 8,372 9,130
Interest expense (22,994) (21,042) (45,459) (39,857)
Other income, net 4,186 (1,946) 8,665 (2,090)
Income (loss) before income taxes 4,744 (530,952) 2,333 (560,988)
Specialty Surgery        
Segment Reporting [Line Items]        
Total revenue, net 309,269 303,958 592,404 584,622
Tissue Reconstruction        
Segment Reporting [Line Items]        
Total revenue, net 109,492 111,647 218,275 213,636
Operating Segments | Specialty Surgery        
Segment Reporting [Line Items]        
Total revenue, net 309,269 303,958 592,404 584,622
Cost of goods sold 130,212 120,243 240,687 230,104
Research and development 14,200 14,627 26,053 29,423
Selling, general & administrative 75,983 83,174 153,664 166,962
Intangible asset amortization 0 0 0 0
Goodwill impairment charge   388,106   388,106
Total costs and expenses 220,395 606,150 420,404 814,595
Operating income (loss) 88,874 (302,192) 172,000 (229,973)
Operating Segments | Tissue Reconstruction        
Segment Reporting [Line Items]        
Total revenue, net 109,492 111,647 218,275 213,636
Cost of goods sold 41,989 56,660 79,448 105,930
Research and development 8,169 6,770 15,701 12,741
Selling, general & administrative 40,394 44,310 83,920 86,614
Intangible asset amortization 0 0 0 0
Goodwill impairment charge   123,259   123,259
Total costs and expenses 90,552 230,999 179,069 328,544
Operating income (loss) 18,940 (119,352) 39,206 (114,908)
Corporate and Other        
Segment Reporting [Line Items]        
Total revenue, net 0 0 0 0
Cost of goods sold 26,816 29,370 53,818 58,460
Research and development 1,884 5,600 6,000 9,561
Selling, general & administrative 56,059 52,406 113,087 107,811
Intangible asset amortization 3,770 3,754 7,546 7,458
Goodwill impairment charge   0   0
Total costs and expenses 88,529 91,130 180,451 183,290
Operating income (loss) $ (88,529) $ (91,130) $ (180,451) $ (183,290)